4.7 Review

A comprehensive review on xanthone derivatives as α-glucosidase inhibitors

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 157, Issue -, Pages 1460-1479

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.07.073

Keywords

Diabetes; alpha-Glucosidase; Inhibition; QSAR; Xanthone

Funding

  1. European Union (FEDER funds) [POCI/01/0145/FEDER/007265]
  2. National Funds (FCT/MEC, Fundacao para a Ciencia e Tecnologia and Ministerio da Educacao e Ciencia) [PT2020 UID/QUI/50006/2013]
  3. FCT [UID/QUI/00062/2013]
  4. Programa Operational Competitividade e Internacionalizacao (COMPETE) [POCI-01-0145-FEDER-029241]
  5. framework of QREN [NORTE-01-0145-FEDER-000024]
  6. Fundação para a Ciência e a Tecnologia [UID/QUI/50006/2013, UID/QUI/00062/2013] Funding Source: FCT

Ask authors/readers for more resources

alpha-Glucosidase plays an important role in carbohydrate metabolism and is therefore an attractive therapeutic target for the treatment of diabetes, obesity and other related complications. In the last two decades, considerable interest has been given to natural and synthetic xanthone derivatives in this field of research. Herein, a comprehensive review of the literature on xanthones as inhibitors of alpha-glucosidase activity, their mechanism of action, experimental procedures and structure-activity relationships have been reviewed for more than 280 analogs. With this overview we intend to motivate and challenge researchers (e.g. chemistry, biology, pharmaceutical and medicinal areas) for the design of novel xanthones as multipotent drugs and exploit the properties of this class of compounds in the management of diabetic complications. (C) 2018 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available